Researchers at the University of Missouri have collaborated with Novartis Pharmaceuticals to develop micelles that can revolutionize the manufacturing process of medicines and enhance clean energy technology. These micelles, derived from amino acids and coconut oil, have a unique structure that allows for efficient electrochemical reactions without toxic solvents. By eliminating the need for harmful chemicals, the micelles could lower the cost of medicine manufacturing and reduce the environmental impact of traditional processes. Additionally, the micelles could be used in electrocatalysis to produce hydrogen fuel from water, offering a clean energy alternative to coal and gas. The development of this technology comes at a critical time as medicine prices continue to rise. While there is debate about the direct impact on drug prices, the use of micelles can contribute to making drugs more affordable for consumers. Furthermore, the potential applications of these micelles extend beyond medicine manufacturing to clean energy production, aligning with efforts to reduce planet-warming pollution and transition to sustainable energy sources. The advancement of hydrogen fuel production through this innovative process opens up possibilities for various industries, including transportation and energy storage. Companies like Honda and Hypermotive are already exploring the use of hydrogen fuel in vehicles, ships, and planes. Overall, the development of these micelles showcases a promising solution for advancing both medicine manufacturing and clean energy technology, guiding us towards a more sustainable and environmentally friendly future.